KKR is in focus after reports that it is nearing a takeover of medical device outsourcer Integer Holdings for about $4.3 billion, with an indicated offer of $127 per share. The stock has recently shown firm short-term momentum with a 7-day share price return of 6.42% and a 30-day return of 10.09%, though the year-to-date return is down 18.04% and the one-year total shareholder return is down 26.43%. Valuation views are split: the most followed narrative on Simply Wall St sets fair value at $84.45, suggesting the stock is overvalued, while the platform's own discounted cash flow model points to a fair value of $139.01, indicating potential upside.
Integer Holdings CorpKKR nearing $4.3B takeover at $127/share, a premium to current price.
KKR & Co. Inc.Acquisition talks and split valuation views create mixed outlook for KKR.
